Vertex Pharmaceuticals Incorpor - stock earnings
VRTX Upcoming estimated earnings
Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
---|---|---|---|---|
May 6, 2024 AfterMarket | 4.76 / 4.14 | - | 2.7 billion / 2.6 billion | - |
VRTX Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | 968.8 million USD | 2.5 billion USD |
2023Q3 | 1.0 billion USD | 2.5 billion USD |
2023Q2 | 915.7 million USD | 2.5 billion USD |
2023Q1 | 699.8 million USD | 2.4 billion USD |
2022Q4 | 818.9 million USD | 2.3 billion USD |
2022Q3 | 930.5 million USD | 2.3 billion USD |
2022Q2 | 810.5 million USD | 2.2 billion USD |
2022Q1 | 762.1 million USD | 2.1 billion USD |
2021Q4 | 770.1 million USD | 2.1 billion USD |
2021Q3 | 851.9 million USD | 2.0 billion USD |
2021Q2 | 66.9 million USD | 1.8 billion USD |
2021Q1 | 653.1 million USD | 1.7 billion USD |
2020Q4 | 604.2 million USD | 1.6 billion USD |
2020Q3 | 667.4 million USD | 1.5 billion USD |
2020Q2 | 837.3 million USD | 1.5 billion USD |
2020Q1 | 602.8 million USD | 1.5 billion USD |
2019Q4 | 583.2 million USD | 1.4 billion USD |
2019Q3 | 57.5 million USD | 949.8 million USD |
2019Q2 | 267.4 million USD | 941.3 million USD |
2019Q1 | 268.6 million USD | 858.4 million USD |
2018Q4 | 1.6 billion USD | 870.1 million USD |
2018Q3 | 128.7 million USD | 784.5 million USD |
2018Q2 | 207.4 million USD | 752.2 million USD |
2018Q1 | 210.3 million USD | 640.8 million USD |
2017Q4 | 100.7 million USD | 651.6 million USD |
2017Q3 | -103.0 million USD | 578.2 million USD |
2017Q2 | 18.0 million USD | 544.1 million USD |
2017Q1 | 247.8 million USD | 714.7 million USD |
2016Q4 | 32.9 million USD | 458.7 million USD |
2016Q3 | -41.8 million USD | 413.8 million USD |
2016Q2 | -64.5 million USD | 431.6 million USD |
2016Q1 | -41.6 million USD | 398.1 million USD |
2015Q4 | -75.5 million USD | 417.9 million USD |
2015Q3 | -95.1 million USD | 309.8 million USD |
2015Q2 | -188.8 million USD | 166.1 million USD |
2015Q1 | -198.6 million USD | 138.5 million USD |
2014Q4 | -176.7 million USD | 144.6 million USD |
2014Q3 | -170.1 million USD | 179.0 million USD |
2014Q2 | -159.4 million USD | 138.4 million USD |
2014Q1 | -232.5 million USD | 118.5 million USD |
2013Q4 | 44.3 million USD | 351.2 million USD |
2013Q3 | -124.1 million USD | 221.7 million USD |
2013Q2 | -57.2 million USD | 310.8 million USD |
2013Q1 | -308.0 million USD | 328.4 million USD |
2012Q4 | -76.1 million USD | 334.0 million USD |
2012Q3 | -57.5 million USD | 336.0 million USD |
2012Q2 | -64.9 million USD | 418.3 million USD |
2012Q1 | 91.6 million USD | 438.7 million USD |
2011Q4 | 158.6 million USD | 563.3 million USD |
2011Q3 | 221.1 million USD | 659.2 million USD |
2011Q2 | -174.1 million USD | 114.4 million USD |
2011Q1 | -176.1 million USD | 73.7 million USD |
2010Q4 | -180.4 million USD | 65.5 million USD |
2010Q3 | -209.0 million USD | 23.8 million USD |
2010Q2 | -200.0 million USD | 31.6 million USD |
2010Q1 | -165.3 million USD | 22.4 million USD |
2009Q4 | -158.6 million USD | 33.9 million USD |
2009Q3 | -149.6 million USD | 25.0 million USD |
2009Q2 | -171.3 million USD | 19.1 million USD |
2009Q1 | -162.7 million USD | 24.0 million USD |
2008Q4 | -142.3 million USD | 32.8 million USD |
2008Q3 | -130.0 million USD | 31.6 million USD |
2008Q2 | -91.3 million USD | 69.4 million USD |
2008Q1 | -96.2 million USD | 41.7 million USD |
2007Q4 | -85.8 million USD | 51.0 million USD |
2007Q3 | -107.0 million USD | 41.0 million USD |
2007Q2 | -117.8 million USD | 38.2 million USD |
2007Q1 | -80.7 million USD | 68.8 million USD |
2006Q4 | -27.3 million USD | 94.3 million USD |
2006Q3 | -51.8 million USD | 53.3 million USD |
2006Q2 | -77.7 million USD | 29.7 million USD |
2006Q1 | -50.1 million USD | 39.1 million USD |
2005Q4 | -38.1 million USD | 63.8 million USD |
2005Q3 | -79.6 million USD | 36.2 million USD |
2005Q2 | -41.0 million USD | 32.3 million USD |
2005Q1 | -44.7 million USD | 28.6 million USD |
2004Q4 | -42.8 million USD | 39.8 million USD |
2004Q3 | -38.8 million USD | 26.8 million USD |
2004Q2 | -44.3 million USD | 18.5 million USD |
2004Q1 | -40.4 million USD | 17.5 million USD |
2003Q4 | -41.0 million USD | 10.6 million USD |
2003Q3 | -86.4 million USD | 18.4 million USD |
2003Q2 | -45.8 million USD | 17.6 million USD |
2003Q1 | 20.6 million USD | 22.6 million USD |
2002Q4 | -32.1 million USD | 43.8 million USD |
2002Q3 | -33.5 million USD | 34.3 million USD |
2002Q2 | -21.0 million USD | 42.3 million USD |
2002Q1 | -3.3 million USD | 51.5 million USD |
2001Q4 | -3.3 million USD | 51.5 million USD |
2001Q3 | -47.0 million USD | 40.4 million USD |
2001Q2 | -12.1 million USD | 21.4 million USD |
2001Q1 | -8.9 million USD | 19.1 million USD |
2000Q4 | -11.3 million USD | 19.7 million USD |
2000Q3 | -24.9 million USD | 13.9 million USD |
2000Q2 | 12.6 million USD | 37.0 million USD |
2000Q1 | -16.2 million USD | 7.5 million USD |
1999Q4 | 1.7 million USD | 29.6 million USD |
1999Q3 | -14.3 million USD | 9.6 million USD |
1999Q2 | -10.8 million USD | 15.3 million USD |
1999Q1 | -17.6 million USD | 4.0 million USD |
1998Q4 | -12.6 million USD | 11.7 million USD |
1998Q3 | -2.3 million USD | 18.4 million USD |
1998Q2 | -9.8 million USD | 7.2 million USD |
1998Q1 | -8.4 million USD | 3.2 million USD |
1997Q4 | -6.8 million USD | 11.2 million USD |
1997Q3 | -5.9 million USD | 13.5 million USD |
1997Q2 | -1.4 million USD | 12.2 million USD |
1997Q1 | -5.8 million USD | 6.9 million USD |
1996Q4 | -3.9 million USD | 4.8 million USD |
1996Q3 | -6.3 million USD | 2.9 million USD |
1996Q2 | -22.3 million USD | 3.1 million USD |
1996Q1 | -7.5 million USD | 2.5 million USD |
1995Q4 | -800000 USD | 8.2 million USD |
1995Q3 | -6.9 million USD | 2.3 million USD |
1995Q2 | -9.0 million USD | 6.5 million USD |
1995Q1 | -4.7 million USD | 5.1 million USD |
1994Q4 | -4.9 million USD | 2.7 million USD |
1994Q3 | -3.9 million USD | 6.5 million USD |
1994Q2 | -5.5 million USD | 4.8 million USD |
1994Q1 | -3.2 million USD | 5.6 million USD |
1993Q4 | 8.7 million USD | 18.0 million USD |
1993Q3 | -2.7 million USD | 4.4 million USD |
1993Q2 | -800000 USD | 4.6 million USD |
1993Q1 | -3.3 million USD | 900000 USD |
1992Q4 | -2.7 million USD | 1.0 million USD |
1992Q3 | -2.2 million USD | 1.0 million USD |
1992Q2 | -1.9 million USD | 1.0 million USD |
1992Q1 | -1.6 million USD | 900000 USD |
1991Q4 | -1.3 million USD | 800000 USD |
1991Q3 | -1.2 million USD | 800000 USD |
1991Q2 | -1.4 million USD | 800000 USD |
1991Q1 | ? USD | 800000 USD |
1990Q4 | ? USD | 600000 USD |
1990Q3 | ? USD | 600000 USD |
1990Q2 | ? USD | 600000 USD |
1990Q1 | ? USD | 500000 USD |
VRTX Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | 3.6 billion USD | 9.8 billion USD |
2022 | 3.3 billion USD | 8.9 billion USD |
2021 | 2.3 billion USD | 7.6 billion USD |
2020 | 2.7 billion USD | 6.2 billion USD |
2019 | 1.2 billion USD | 4.2 billion USD |
2018 | 2.1 billion USD | 3.0 billion USD |
2017 | 263.5 million USD | 2.5 billion USD |
2016 | -112.1 million USD | 1.7 billion USD |
2015 | -558.1 million USD | 1.0 billion USD |
2014 | -738.6 million USD | 580.4 million USD |
2013 | -445.0 million USD | 1.2 billion USD |
2012 | -107.0 million USD | 1.5 billion USD |
2011 | 29.6 million USD | 1.4 billion USD |
2010 | -754.6 million USD | 143.4 million USD |
2009 | -641.6 million USD | 102.0 million USD |
2008 | -459.9 million USD | 175.5 million USD |
2007 | -391.3 million USD | 199.0 million USD |
2006 | -206.9 million USD | 216.4 million USD |
2005 | -203.4 million USD | 160.9 million USD |
2004 | -166.2 million USD | 102.7 million USD |
2003 | -196.8 million USD | 69.1 million USD |
2002 | -108.6 million USD | 161.1 million USD |
2001 | -66.2 million USD | 167.5 million USD |
2000 | -39.7 million USD | 78.1 million USD |
1999 | -41.0 million USD | 61.6 million USD |
1998 | -33.1 million USD | 44.4 million USD |
1997 | -19.8 million USD | 43.8 million USD |
1996 | -40.0 million USD | 13.3 million USD |
1995 | -21.5 million USD | 22.1 million USD |
1994 | -17.6 million USD | 19.6 million USD |
1993 | 2.0 million USD | 27.9 million USD |
1992 | -8.5 million USD | 3.8 million USD |
1991 | -5.1 million USD | 3.2 million USD |
1990 | -4.3 million USD | 2.3 million USD |
VRTX
Price: $402.50
52 week price:
Earnings Per Share: 13.87 USD
P/E Ratio: 32.17
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.1 million
Ebitda: 142.2 millionMarket Capitalization: 102.8 billion